Market Overview

Jim Cramer Gives His Opinion On GlaxoSmithKline, Abbott Laboratories And More

Share:
Related
Benzinga's Top Upgrades, Downgrades For October 11, 2018
William Blair: SiteOne Landscape Supply Could Have Robust 2018 With M&A, Margin Expansion
Related CWST
3 Biggest Price Target Changes For Friday
Benzinga's Top Upgrades, Downgrades For December 28, 2018

On CNBC's "Mad Money Lightning Round", Jim Cramer said he would take a big pass on SiteOne Landscape Supply Inc (NYSE: SITE). He explained that people don't like housing right now and the stock is going to be affiliated with the housing group.

Instead of Casella Waste Systems Inc. (NASDAQ: CWST), Cramer would rather buy Waste Management, Inc. (NYSE: WM).

Cramer thinks there are much better drug stocks than GlaxoSmithKline plc (NYSE: GSK).

Abbott Laboratories (NYSE: ABT) is terrific, said Cramer. He thinks the CEO has done a remarkable job. The company has a fantastic balance sheet and its device business is red-hot, added Cramer.

Posted-In: CNBC Jim Cramer Mad Money mad money Lightning RoundMedia

 

Related Articles (CWST + ABT)

View Comments and Join the Discussion!

Bulls & Bears Of The Week: Apple, Ford, Nike, Verizon And More

IPO Outlook For The Week: Tencent Music, Mobile Homes And A Fintech Company